Company Overview
Snapshot
Founded in May 2004 by Orit Nadav and Meir Redlich, Aerodentis operates with 1–10 employees. The company has secured funding across one disclosed round. In March 2017, the University of Alabama at Birmingham School of Dentistry initiated a clinical trial for Aerodentis's new braces treatment, signaling significant validation for its innovative orthodontic technology.
Business overview
Aerodentis develops an orthodontic treatment system designed to straighten teeth while users sleep, offering an alternative to conventional braces and clear aligners. The system applies customizable, electronically controlled pulsating force to gradually reposition teeth, utilizing a thermoplastic mold with an integrated inflatable silicon balloon. This device is custom-made through CAD/CAM manufacturing and 3D imaging, connecting to a console that manages air pressure and monitors patient compliance. Aerodentis targets the dental technology market, serving patients and providers within the healthcare sector.
Strategic signal
In March 2017, the University of Alabama at Birmingham School of Dentistry launched a clinical trial for Aerodentis's braces treatment, which uses pulsating air to correct crowded teeth. This development is significant as it indicates a move towards mainstream adoption and validation of Aerodentis's technology within a reputable academic setting. For investors, this signals a strong potential for market penetration and a de-risking of the technology through rigorous clinical evaluation.
Log in to access full profile ›Company Intelligence Q&A
- What is Aerodentis's core product?
- Aerodentis offers a treatment system for straightening teeth that uses a custom-made mouthpiece with an integrated inflatable silicon balloon and a console to apply electronically controlled pulsating force while the user sleeps.
- When was Aerodentis founded and by whom?
- Aerodentis was founded in May 2004 by Orit Nadav and Meir Redlich.
- What significant clinical validation did Aerodentis receive?
- In March 2017, the University of Alabama at Birmingham School of Dentistry began a clinical trial for Aerodentis's new braces treatment, which utilizes pulsating air to correct crowded teeth.
- In which markets has Aerodentis's device been sold to dental professionals?
- As of February 2014, Aerodentis's device had been sold to dental professionals in Israel, Switzerland, and Spain.
- What regulatory milestone did Aerodentis achieve?
- In February 2014, Aerodentis earned the European CE Mark for its device, with FDA approval anticipated within two years of that date.